Graduate School of Medical Sciences
A partnership with the Sloan Kettering Institute

News

Most of the reasons why American patients receive care from multiple providers are related to numerous modifiable causes such as patient preferences, physician referrals and health system factors —not medical need—according to a qualitative study by Weill Cornell Medicine researchers.  

“The results of our study show that fragmentation is not just a function of sicker patients seeing more providers,” said first author Dr. Lisa Kern, an associate professor of medicine and of healthcare...

Read More

For first-year Weill Cornell Graduate School of Medical Sciences doctoral student Suniyya Amna Waraich, developing new therapies for stroke patients is personal: A close relative was at a family gathering when he had a stroke. Fortunately, the doctors in her family were able to diagnose it early, she said, he has recovered well as a result.

“But even in his case, the weight of constant wariness and anticipation of another stroke is impossible to shake,” said Waraich, who is studying...

Read More

Chelsea Clinton is a public health advocate, researcher and educator. But being a mother has deepened her passion for children’s health, she explained in a talk on Feb. 5 at Weill Cornell Medicine.

Clinton, a member of Weill Cornell Medicine’s Board of Overseers, spoke to students and faculty about her passion for children’s health as part of the Luminaries in Healthcare Leadership series, during which industry leaders share their perspectives and expertise on cutting-edge issues...

Read More

New studies from Weill Cornell Medicine researchers have revealed the importance of two gene-regulation proteins in the development of common immune cell cancers called lymphomas.

The studies, published Dec. 10 in Nature Immunology and Oct. 1 in Cancer Discovery, showed that one of the proteins, LSD1, plays a major role in starting and sustaining lymphomas, while the other, TET2, normally prevents lymphomas from developing. The discoveries point to the possibility of new lymphoma...

Read More

New York (January 10, 2019)—Dr. Barbara Hempstead, a preeminent physician-scientist, educator and academic leader, has been appointed dean of the Weill Cornell Graduate School of Medical Sciences, effective Jan. 14. She succeeds Dr. Carl Nathan, who led the graduate school since 2017 and completed a planned two-year term.

The Weill Cornell Graduate School of Medical Sciences offers professional scientific training for doctoral students, researchers in health policy and healthcare...

Read More

In 2013, scientists at MIT and at UC Berkeley optimized a way to use bacterial gene sequences to cut and change DNA at precise locations. The genome-editing system, called CRISPR, is cheaper and simpler than previous methods, and it has led to breakthroughs in diagnostics and the creation of more accurate disease models. And because it can permanently modify a living organism’s DNA, CRISPR technology may one day allow physicians to treat genetic diseases—anything from congenital deafness to...

Read More

Seven Weill Cornell Medicine faculty members leading multi-institutional research teams were awarded grants from The Starr Foundation's 12th Starr Cancer Consortium Grant Competition to fund their innovative cancer research projects.

The Starr Cancer Consortium, established in 2006 through a generous gift from The Starr Foundation, advances research in new ways that will improve the understanding, diagnosis, prevention and treatment of cancer. The consortium is a...

Read More

By Molly Schulson
Illustrations by Aaron Sacco

For three Weill Cornell Medicine summer training programs—all dedicated to helping socioeconomically disadvantaged or minority undergraduates explore careers in the medical sciences—this is a milestone year. Two of them, Advancing Cornell Career Experiences for Science Students (ACCESS) and Gateways to the Laboratory, mark 25 years of service, while the Travelers Summer Research Fellowship celebrates 50. All three provide research...

Read More

A protein induced by gut microbes is vital in healing colons that have become inflamed due to a short-term form of colitis, Weill Cornell Medicine researchers discovered in a new study. However, they also found that this molecule, called TNF-like ligand 1A (TL1A) contributes to the sustained inflammation characterized by chronic inflammatory bowel disease (IBD).

In a study published Dec. 11 in Immunity, Dr. Randy Longman, an assistant professor of medicine in the Division of...

Read More

By Beth Saulnier
Photos by Stephanie Diani

When Dr. Sandeep “Sunny” Kishore, PhD ’12, MD ’14, gave the commencement speech for the Class of 2014, he stood onstage in Carnegie Hall and confessed something: as a third-year medical student, he’d initially failed his surgical “shelf” exam, one of the rigorous tests given after each core rotation. Having resumed his MD studies after a lauded five years as a doctoral candidate and a postdoctoral fellow at Harvard Medical School—which included...

Read More

Weill Cornell Medicine Graduate School of Medical Sciences 1300 York Ave. Box 65 New York, NY 10065 Phone: (212) 746-6565 Fax: (212) 746-8906